AB1160 Questionnaire Survey Evaluating Hyperuricemia-Related Control Knowledge on 280 Patients with Gout
Authors: P. Zhang, Y. Mou, J. Gu
Journal: Annals of the Rheumatic Diseases (2015)

<h3>Background</h3> Gout is a type of crystal-related arthropathy characterized by deposition of monosodium urate within joints after chronic hyperuricemia.Although gout is increasing in incidence across all ethnicities and has a wellunderstood pathogenesis and effective treatments, but remains suboptimally managed,As a chronic disease, the patients9 own understanding of the disease and their self-management is very important. <h3>Objectives</h3> To investigate hyperuricemia-related control knowledge of patients and identify the target of health education for patients with gout. <h3>Methods</h3> 289 continuous patients with primary gout were interviewed with self-designed questionnaire including patient9s demographic data, the assessment of disease burden and 10 questions about hyperuricemia-related Control knowledge. <h3>Results</h3> 280 valid questionnaires were collected. The mean of all patients9 correctly answered items was 4.5±1.5. The participants were considered having diet control knowledge if he or she correctly answered ≥6 items and the rate of having knowledge for all patients was 22.5%, it was lower in male than female. 82.5% of patients were well informed about the hazard of seafood, organ meat or alcohol for gout control and 53.0% of patients knew the minimum daily water that should be intake for patients with hyperuricemia,but 66.0% of patients thought that uric acid lowering drugs should be used in acute gout episodes, and only 36.0% thought that asymptomatic hyperuricemia also need for treatment. Only 21.4% of the patients knew the ideal serum uric acid level for optimal treatment of gout. 36.4% of patients understand that hyperuricemia is associated with many diseases and is an independent risk factor with diseases,such as cardiovascular disease, kidney disease et al. 20.4% of gout patients were aware of that they needed lfelong medication.Besides,we also investigated about the issues of urate-lowering drug discontinuation in patients, we found that 61.0% of patients would discontinue urate-lowering drug, among which a third believed that gout attack is occasional,and there was no need of long-term medication.Logistic regression revealed that gender and acute attack frequency significantly predicted that patients had hyperuricemia-Related Control Knowledge. <h3>Conclusions</h3> A considerable part of gout patients do not understood the relevant knowledge of hyperuricemia control,and patient education should be strengthened in the future, especially in men with recurrent gout. <h3>References</h3> Roddy E, Zhang W, Doherty M. The changing epidemiology of gout. Nature Clinical Practice Rheumatology 2007;3:443–9. Doherty M. New insights into the epidemiology of gout. Rheumatology 2009;48 (Suppl 2):2–8. Doherty M, Jansen T L, Nuki G, et al. Gout: why is this curable disease so seldom cured? [J]. Ann Rheum Dis,2012,71(11):1765-1770. Rees F, Jenkins W, Doherty M. Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study [J]. Ann Rheum Dis,2013,72(6):826-830. Li QH, Dai L, Li ZX, et al. Questionnaire survey evaluating disease-related knowledge for 149 primary gout patients and 184 doctors in South China [J]. Clin Rheumatol,2013,32(11):1633-1640. <h3>Disclosure of Interest</h3> None declared